...
首页> 外文期刊>World Journal of Surgical Oncology >Comparison of open and intracorporeal modified ureterosigmoidostomy (Mainz II) after laparoscopic radical cystectomy with bladder cancer
【24h】

Comparison of open and intracorporeal modified ureterosigmoidostomy (Mainz II) after laparoscopic radical cystectomy with bladder cancer

机译:腹腔镜膀胱切除术后腹腔椎间盘切除术后的开放和体内改性输尿管肌肌瘤术(Mainz II)的比较

获取原文
           

摘要

To compare perioperative and oncologic outcomes of open modified ureterosigmoidostomy urinary diversion (OMUUD) and intracorporeal modified ureterosigmoidostomy urinary diversion (IMUUD) following laparoscopic radical cystectomy (LRC). We retrospectively reviewed our single institutional collected database patients undergoing LRC from October 2011 to October 2019. The perioperative characteristics were compared between OMUUD and IMUUD, and overall survival (OS) and progression-free survival (PFS) were evaluated by the Kaplan-Meier method. Overall, 84 patients were included. OMUUD and IMUUD were performed in 63 (75%) and 21 (25%) patients, respectively. IMUUD patients demonstrated shorter postoperative length of stay (16.24 ± 3.91 days vs. 18.98 ± 7.41 days, P = 0.033), similar operation time (498.57 ± 121.44 vs. 462.24 ± 99.71, P = 0.175), similar estimated blood loss [400 (200–475) ml vs. 400 (200–700) ml, P = 0.095], and similar overall complication rate within 30 days (19.05% vs. 25.40%, P = 0.848) and 90 days (23.81% vs. 17.46%, P = 0.748). Complete urinary control rate was 87.3% (55/63) in the OMUUD group. In IMUUD, the complete urinary control rate was 90.5% (19/21). There was no significant difference in OS (χ2 = 0.015, P = 0.901) and PFS (χ2 = 0.107, P = 0.743) between the two groups. IMUUD postoperative recovery is faster; other perioperative outcomes and oncology results are not significantly different with OMUUD. It is indicated that IMUUD can be utilized safely and effectively in the urinary diversion after LRC.
机译:比较腹腔镜自由基膀胱切除术(LRC)后开放修饰的输尿管肌瘤尿术尿液转移(OMUUD)和体内修饰的输尿管肌瘤术治疗(IMUUD)的围手术和肿瘤结果。我们回顾性地审查了2011年10月至2019年10月接受过LRC的单一机构收集的数据库患者。通过Kaplan-Meier方法评估了祖美和Imuud之间的围手术期特征,并通过Kaplan-Meier方法评估了整体存活率(OS)和无进展生存率(PFS) 。总体而言,包括84名患者。 OMUUD和IMUUD分别在63(75%)和21例(25%)患者中进行。 IMUUD患者术后术后较短(16.24±3.91天,P = 0.033),类似操作时间(498.57±121.44与462.24±99.71,P = 0.175),类似的估计失血[400( 200-475)ML与400(200-700)mL,P = 0.095],30天内类似的整体并发症率(19.05%与25.40%,p = 0.848)和90天(23.81%与17.46%) ,p = 0.748)。在omuud组中完全泌尿控制率为87.3%(55/63)。在IMUUD中,完全的泌尿控制率为90.5%(19/21)。两组之间的OS(χ2= 0.015,p = 0.901)和PFS(χ2= 0.107,p = 0.743)没有显着差异。 IMUUD术后恢复更快;其他围手术期结果和肿瘤结果与欧姆没有显着不同。表示可以在LRC后的尿液转移中安全有效地使用IMUUD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号